← Eichor
Study identifier: NCT05422040 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dry Needlig Vesus Tecartherapy in Low-back Pain Treatment

Condition: Low Back Pain  ·  Sponsor: University of Alcala

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Introduction: Diathermy is a new tool that could help subjects with chronic low back pain (CLBP), with no studies having compared it to other interventions already investigated such as dry needling. Hypothesis: Diathermy is more effective than dry needling in improving pain intensity in the short term in subjects with CLBP. Design: randomised controlled trial Methods: We will conduct a convenience sampling, with subjects receiving 2 treatment sessions with diathermy or dry needling, according to allocation. Subjects will be assessed at baseline, 1 week, 1 month and 3 months after treatment for pain intensity, disability, kinesiophobia and catastrophizing. Analysis of variance (ANOVA) and moderation analysis will be performed to evaluate the results, with 95% confidence intervals (CI).

This description comes directly from the study's public registry record.

Talk to the study team

Patricia M Martínez - Merinero, PhD  ·  +34683378391  ·  info@institutofisioterapiaydolor.es

Always discuss trial participation with your own doctor first.

Locations (1)

Centro Investigación Fisioterapia y DolorAlcalá de Henares, Madrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05422040